| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.705 | 0.003 | 0.705 | Anesthetic local | 0.532 0.004 CID_3015693 | ||
| 0.557 | 0.012 | 0.56 | Calcium channel L-type activator | 0.56 0.011 CID_3015693 | CID_3015693 | |
| 0.482 | 0.009 | 0.482 | Anesthetic general | 0.333 0.027 CID_3015693 | ||
| 0.455 | 0.039 | 0.455 | Aldehyde oxidase inhibitor | 0.177 0.118 CID_3015693 | ||
| 0.426 | 0.018 | 0.426 | Sigma receptor agonist | 0.118 0.117 CID_3015693 | ||
| 0.447 | 0.053 | 0.447 | 5 Hydroxytryptamine release inhibitor | 0.34 0.125 CID_3015693 | ||
| 0.413 | 0.023 | 0.413 | Amyloid beta aggregation inhibitor | 0.341 0.037 CID_3015693 | ||
| 0.412 | 0.027 | 0.412 | Cardiotonic | 0.304 0.054 CID_3015693 | ||
| 0.366 | 0.004 | 0.366 | Porphobilinogen synthase inhibitor | 0.181 0.015 CID_3015693 | ||
| 0.359 | 0.014 | 0.359 | Tyrosine 3 hydroxylase inhibitor | 0.285 0.041 CID_3015693 | ||
| 0.388 | 0.043 | 0.388 | Spasmolytic | 0.273 0.081 CID_3015693 | ||
| 0.371 | 0.038 | 0.371 | Calcium channel activator | 0.327 0.067 CID_3015693 | ||
| 0.344 | 0.014 | 0.344 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.253 0.041 CID_3015693 | ||
| 0.355 | 0.027 | 0.355 | Peroxidase inhibitor | 0.263 0.045 CID_3015693 | ||
| 0.382 | 0.071 | 0.382 | Calpain 2 inhibitor | 0.366 0.079 CID_3015693 | ||
| 0.346 | 0.037 | 0.346 | Superoxide dismutase inhibitor | 0.281 0.058 CID_3015693 | ||
| 0.41 | 0.111 | 0.41 | DNA directed DNA polymerase inhibitor | 0.318 0.153 CID_3015693 | ||
| 0.352 | 0.072 | 0.352 | Thyroid hormone antagonist | 0.318 0.085 CID_3015693 | ||
| 0.33 | 0.056 | 0.33 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.219 0.09 CID_3015693 | ||
| 0.272 | 0.014 | 0.272 | Chelator | 0.182 0.028 CID_3015693 | ||
| 0.321 | 0.078 | 0.321 | Thyroid hormone beta antagonist | 0.295 0.091 CID_3015693 | ||
| 0.29 | 0.05 | 0.348 | 5 Hydroxytryptamine uptake stimulant | 0.348 0.026 CID_3015693 | CID_3015693 | |
| 0.365 | 0.129 | 0.365 | Alpha-glucosidase inhibitor | 0.3 0.16 CID_3015693 | ||
| 0.293 | 0.06 | 0.293 | DNA damaging | 0.265 0.073 CID_3015693 | ||
| 0.277 | 0.051 | 0.301 | Gastrin inhibitor | 0.301 0.032 CID_3015693 | CID_3015693 | |
| 0.326 | 0.099 | 0.339 | GABA C receptor rho-3 antagonist | 0.339 0.092 CID_3015693 | CID_3015693 | |
| 0.283 | 0.058 | 0.283 | Antiamyloidogenic | 0.232 0.08 CID_3015693 | ||
| 0.341 | 0.118 | 0.341 | Beta lactamase inhibitor | 0.223 0.171 CID_3015693 | ||
| 0.36 | 0.138 | 0.36 | Caspase 9 stimulant | |||
| 0.328 | 0.11 | 0.328 | Histamine release inhibitor | 0.217 0.184 CID_3015693 | ||
| 0.354 | 0.138 | 0.354 | DNA polymerase beta inhibitor | 0.271 0.18 CID_3015693 | ||
| 0.282 | 0.07 | 0.282 | Insulysin inhibitor | 0.267 0.082 CID_3015693 | ||
| 0.213 | 0.018 | 0.213 | Toll-Like receptor 2 antagonist | 0.206 0.021 CID_3015693 | ||
| 0.314 | 0.122 | 0.314 | 15-Lipoxygenase inhibitor | 0.237 0.176 CID_3015693 | ||
| 0.243 | 0.056 | 0.3 | Peptidyltransferase inhibitor | 0.3 0.024 CID_3015693 | CID_3015693 | |
| 0.285 | 0.101 | 0.302 | Vasodilator, coronary | 0.302 0.085 CID_3015693 | CID_3015693 | |
| 0.242 | 0.064 | 0.242 | Neuropeptide Y2 antagonist | 0.227 0.08 CID_3015693 | ||
| 0.319 | 0.145 | 0.319 | Transcription factor inhibitor | 0.259 0.18 CID_3015693 | ||
| 0.25 | 0.079 | 0.25 | Interleukin agonist | 0.213 0.109 CID_3015693 | ||
| 0.224 | 0.058 | 0.224 | DNA methyltransferase I inhibitor | 0.144 0.111 CID_3015693 | ||
| 0.264 | 0.104 | 0.264 | Interleukin 2 agonist | 0.263 0.105 CID_3015693 | ||
| 0.191 | 0.037 | 0.205 | Alpha-N-acetylglucosaminidase inhibitor | 0.205 0.033 CID_3015693 | CID_3015693 | |
| 0.193 | 0.04 | 0.193 | Death-associated protein kinase 2 inhibitor | 0.153 0.099 CID_3015693 | ||
| 0.205 | 0.053 | 0.205 | Lipocortins synthesis antagonist | |||
| 0.157 | 0.005 | 0.158 | Acetyl-CoA transferase inhibitor | 0.158 0.005 CID_3015693 | CID_3015693 | |
| 0.31 | 0.165 | 0.31 | Apoptosis agonist | 0.299 0.173 CID_3015693 | ||
| 0.157 | 0.017 | 0.157 | Electrolyte absorption antagonist | 0.107 0.049 CID_3015693 | ||
| 0.22 | 0.083 | 0.244 | Free radical scavenger | 0.244 0.071 CID_3015693 | CID_3015693 | |
| 0.232 | 0.095 | 0.232 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.186 | 0.051 | 0.186 | ATPase inhibitor | 0.152 0.098 CID_3015693 | ||
| 0.17 | 0.037 | 0.17 | Alkylator | 0.147 0.048 CID_3015693 | ||
| 0.187 | 0.054 | 0.187 | Cytidine deaminase inhibitor | |||
| 0.205 | 0.076 | 0.205 | DNA methylase inhibitor | |||
| 0.226 | 0.098 | 0.226 | Antioxidant | 0.217 0.103 CID_3015693 | ||
| 0.179 | 0.051 | 0.179 | Lipid peroxidase inhibitor | 0.165 0.059 CID_3015693 | ||
| 0.156 | 0.029 | 0.16 | Sphingosine 1-phosphate receptor 4 antagonist | 0.16 0.025 CID_3015693 | CID_3015693 | |
| 0.134 | 0.008 | 0.134 | Maillard reaction inhibitor | 0.133 0.008 CID_3015693 | ||
| 0.211 | 0.086 | 0.22 | Hypolipemic | 0.22 0.082 CID_3015693 | CID_3015693 | |
| 0.146 | 0.025 | 0.157 | Urease inhibitor | 0.157 0.02 CID_3015693 | CID_3015693 | |
| 0.216 | 0.098 | 0.243 | Calpain inhibitor | 0.243 0.072 CID_3015693 | CID_3015693 | |
| 0.139 | 0.021 | 0.139 | NADH dehydrogenase inhibitor | 0.089 0.057 CID_3015693 | ||
| 0.246 | 0.132 | 0.263 | Sodium/bile acid cotransporter inhibitor | 0.263 0.115 CID_3015693 | CID_3015693 | |
| 0.156 | 0.044 | 0.156 | Nav1.3 sodium channel blocker | 0.151 0.047 CID_3015693 | ||
| 0.155 | 0.044 | 0.155 | Cyclooxygenase 3 inhibitor | 0.122 0.076 CID_3015693 | ||
| 0.167 | 0.058 | 0.225 | Heat shock protein 90 antagonist | 0.225 0.028 CID_3015693 | CID_3015693 | |
| 0.246 | 0.137 | 0.246 | Thioredoxin glutathione reductase inhibitor | |||
| 0.23 | 0.122 | 0.23 | 12-Lipoxygenase inhibitor | 0.23 0.122 CID_3015693 | ||
| 0.149 | 0.042 | 0.182 | Sphingosine 1-phosphate receptor 2 antagonist | 0.182 0.014 CID_3015693 | CID_3015693 | |
| 0.174 | 0.067 | 0.221 | Heat shock protein 90 alpha antagonist | 0.221 0.038 CID_3015693 | CID_3015693 | |
| 0.127 | 0.024 | 0.127 | Telomerase inhibitor | 0.098 0.034 CID_3015693 | ||
| 0.142 | 0.042 | 0.148 | Papain-like protease (SARS coronavirus) inhibitor | 0.148 0.036 CID_3015693 | CID_3015693 | |
| 0.112 | 0.012 | 0.112 | CC chemokine 5 receptor agonist | 0.091 0.036 CID_3015693 | ||
| 0.129 | 0.032 | 0.129 | Prolactin inhibitor | 0.092 0.064 CID_3015693 | ||
| 0.153 | 0.057 | 0.158 | Sphingosine 1-phosphate receptor 5 antagonist | 0.158 0.049 CID_3015693 | CID_3015693 | |
| 0.21 | 0.114 | 0.228 | Immunostimulant | 0.228 0.106 CID_3015693 | CID_3015693 | |
| 0.135 | 0.041 | 0.135 | Nav1.4 sodium channel blocker | 0.11 0.063 CID_3015693 | ||
| 0.137 | 0.044 | 0.137 | Ferrochelatase inhibitor | 0.118 0.055 CID_3015693 | ||
| 0.143 | 0.051 | 0.152 | Proteasome inhibitor | 0.152 0.045 CID_3015693 | CID_3015693 | |
| 0.146 | 0.055 | 0.157 | Heat shock protein 70 antagonist | 0.157 0.032 CID_3015693 | CID_3015693 | |
| 0.17 | 0.08 | 0.17 | Dual specificity phosphatase 3 inhibitor | 0.141 0.105 CID_3015693 | ||
| 0.15 | 0.062 | 0.15 | RET inhibitor | 0.122 0.078 CID_3015693 | ||
| 0.169 | 0.082 | 0.169 | Succinate dehydrogenase inhibitor | 0.168 0.083 CID_3015693 | ||
| 0.113 | 0.027 | 0.113 | Glutathione S-transferase inhibitor | 0.11 0.029 CID_3015693 | ||
| 0.131 | 0.046 | 0.131 | TRPA1 agonist | 0.109 0.073 CID_3015693 | ||
| 0.107 | 0.023 | 0.107 | Phenylalanine 4-hydroxylase inhibitor | 0.06 0.058 CID_3015693 | ||
| 0.188 | 0.104 | 0.188 | ErbB-1 antagonist | |||
| 0.19 | 0.107 | 0.207 | Nitric-oxide synthase stimulant | 0.207 0.078 CID_3015693 | CID_3015693 | |
| 0.182 | 0.1 | 0.219 | 5 Hydroxytryptamine 3E antagonist | 0.219 0.038 CID_3015693 | CID_3015693 | |
| 0.143 | 0.061 | 0.143 | Nav1.2 sodium channel blocker | |||
| 0.126 | 0.044 | 0.126 | Nav1.1 sodium channel blocker | |||
| 0.094 | 0.013 | 0.109 | Heat shock protein 90 beta antagonist | 0.109 0.009 CID_3015693 | CID_3015693 | |
| 0.125 | 0.044 | 0.125 | Butyrylcholinesterase inhibitor | 0.088 0.072 CID_3015693 | ||
| 0.103 | 0.022 | 0.104 | Estrogen-related receptor beta agonist | 0.104 0.021 CID_3015693 | CID_3015693 | |
| 0.226 | 0.146 | 0.226 | Transcription factor NF kappa B inhibitor | 0.205 0.164 CID_3015693 | ||
| 0.122 | 0.043 | 0.145 | Carbonic anhydrase III inhibitor | 0.145 0.03 CID_3015693 | CID_3015693 | |
| 0.102 | 0.025 | 0.123 | GABA aminotransferase inhibitor | 0.123 0.015 CID_3015693 | CID_3015693 | |
| 0.293 | 0.222 | 0.293 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.29 0.227 CID_3015693 | ||
| 0.104 | 0.037 | 0.107 | Glutamate release inhibitor | 0.107 0.033 CID_3015693 | CID_3015693 | |
| 0.173 | 0.106 | 0.173 | Neurotrophic factor enhancer | 0.17 0.11 CID_3015693 | ||
| 0.158 | 0.092 | 0.159 | Phospholipase C inhibitor | 0.159 0.089 CID_3015693 | CID_3015693 | |
| 0.153 | 0.091 | 0.153 | Dual specificity phosphatase inhibitor | 0.13 0.12 CID_3015693 | ||
| 0.118 | 0.056 | 0.157 | Mucolytic | 0.157 0.028 CID_3015693 | CID_3015693 | |
| 0.085 | 0.024 | 0.085 | Potassium channel (ATP-sensitive) blocker | 0.073 0.037 CID_3015693 | ||
| 0.154 | 0.092 | 0.172 | Neurotensin receptor agonist | 0.172 0.06 CID_3015693 | CID_3015693 | |
| 0.111 | 0.05 | 0.111 | UDP-glucose 4-epimerase inhibitor | 0.105 0.056 CID_3015693 | ||
| 0.193 | 0.134 | 0.276 | DNA synthesis inhibitor | 0.276 0.053 CID_3015693 | CID_3015693 | |
| 0.065 | 0.006 | 0.065 | Alpha 1L adrenoreceptor agonist | 0.064 0.007 CID_3015693 | ||
| 0.063 | 0.008 | 0.063 | Acetyl-CoA transferase 1 inhibitor | 0.063 0.008 CID_3015693 | ||
| 0.093 | 0.039 | 0.093 | D-Ala-D-Ala ligase inhibitor | 0.093 0.039 CID_3015693 | ||
| 0.153 | 0.1 | 0.153 | Catenin beta inhibitor | |||
| 0.07 | 0.017 | 0.07 | Dihydroorotate oxidase inhibitor | 0.068 0.019 CID_3015693 | ||
| 0.07 | 0.019 | 0.076 | Beta 2 adrenoreceptor agonist | 0.076 0.012 CID_3015693 | CID_3015693 | |
| 0.104 | 0.055 | 0.104 | Creatine kinase inhibitor | 0.098 0.061 CID_3015693 | ||
| 0.162 | 0.115 | 0.162 | Anticonvulsant | 0.149 0.13 CID_3015693 | ||
| 0.071 | 0.025 | 0.075 | Gonadotropin-releasing hormone receptor agonist | 0.075 0.021 CID_3015693 | CID_3015693 | |
| 0.106 | 0.06 | 0.139 | Carbonic anhydrase XV inhibitor | 0.139 0.035 CID_3015693 | CID_3015693 | |
| 0.089 | 0.044 | 0.089 | Glycine receptor antagonist | |||
| 0.19 | 0.148 | 0.191 | Transcription factor STAT3 inhibitor | 0.191 0.146 CID_3015693 | CID_3015693 | |
| 0.121 | 0.081 | 0.121 | Amylase inhibitor | |||
| 0.118 | 0.079 | 0.118 | Acetylcholinesterase inhibitor | |||
| 0.125 | 0.088 | 0.125 | Nav1.6 sodium channel blocker | |||
| 0.195 | 0.158 | 0.195 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.09 | 0.056 | 0.09 | Histamine N-methyltransferase inhibitor | |||
| 0.134 | 0.1 | 0.134 | Ca2+-transporting ATPase inhibitor | 0.131 0.115 CID_3015693 | ||
| 0.132 | 0.098 | 0.159 | Adenylate cyclase stimulant | 0.159 0.048 CID_3015693 | CID_3015693 | |
| 0.105 | 0.071 | 0.105 | Cystathionine beta-synthase inhibitor | 0.095 0.083 CID_3015693 | ||
| 0.098 | 0.066 | 0.098 | Anabolic | 0.092 0.075 CID_3015693 | ||
| 0.066 | 0.035 | 0.071 | Bombesin 1 receptor agonist | 0.071 0.03 CID_3015693 | CID_3015693 | |
| 0.135 | 0.105 | 0.135 | CF transmembrane conductance regulator agonist | 0.132 0.114 CID_3015693 | ||
| 0.108 | 0.079 | 0.108 | Estrogen antagonist | 0.104 0.088 CID_3015693 | ||
| 0.173 | 0.146 | 0.173 | RNA-directed DNA polymerase inhibitor | |||
| 0.054 | 0.027 | 0.054 | Sodium/calcium exchanger inhibitor | |||
| 0.035 | 0.009 | 0.035 | Estrogen-related receptor gamma antagonist | |||
| 0.097 | 0.071 | 0.097 | Estrogen receptor beta antagonist | |||
| 0.066 | 0.04 | 0.08 | Beta 3 adrenoreceptor antagonist | 0.08 0.024 CID_3015693 | CID_3015693 | |
| 0.061 | 0.036 | 0.061 | Ryanodine receptor antagonist | |||
| 0.095 | 0.072 | 0.095 | Gastric antisecretory | |||
| 0.131 | 0.108 | 0.134 | Interferon gamma antagonist | 0.134 0.103 CID_3015693 | CID_3015693 | |
| 0.087 | 0.064 | 0.096 | Potassium channel activator | 0.096 0.052 CID_3015693 | CID_3015693 | |
| 0.188 | 0.165 | 0.188 | Prostaglandin dehydrogenase inhibitor | |||
| 0.11 | 0.088 | 0.112 | M17 leucyl aminopeptidase inhibitor | 0.112 0.085 CID_3015693 | CID_3015693 | |
| 0.065 | 0.043 | 0.065 | Carbonic anhydrase inhibitor | 0.058 0.048 CID_3015693 | ||
| 0.115 | 0.093 | 0.115 | Alkaline phosphatase inhibitor | |||
| 0.026 | 0.005 | 0.026 | Estrogen-related receptor gamma agonist | 0.02 0.01 CID_3015693 | ||
| 0.107 | 0.087 | 0.107 | Aldehyde dehydrogenase inhibitor | |||
| 0.117 | 0.096 | 0.122 | Vanilloid 1 agonist | 0.122 0.082 CID_3015693 | CID_3015693 | |
| 0.059 | 0.039 | 0.067 | Botulinum neurotoxin type A inhibitor | 0.067 0.028 CID_3015693 | CID_3015693 | |
| 0.087 | 0.067 | 0.087 | Potassium channel (Ca-activated) activator | |||
| 0.056 | 0.037 | 0.06 | Adenine nucleotide translocase inhibitor | 0.06 0.029 CID_3015693 | CID_3015693 | |
| 0.05 | 0.033 | 0.05 | Topoisomerase II beta inhibitor | |||
| 0.07 | 0.053 | 0.07 | Aminopeptidase I inhibitor | |||
| 0.085 | 0.068 | 0.085 | Triose-phosphate isomerase inhibitor | 0.084 0.068 CID_3015693 | ||
| 0.054 | 0.037 | 0.054 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.055 | 0.039 | 0.055 | Carbonic anhydrase II inhibitor | 0.05 0.044 CID_3015693 | ||
| 0.061 | 0.045 | 0.108 | NMDA receptor agonist | 0.108 0.016 CID_3015693 | CID_3015693 | |
| 0.088 | 0.073 | 0.088 | Potassium channel (Voltage-sensitive) activator | 0.087 0.073 CID_3015693 | ||
| 0.06 | 0.045 | 0.091 | NMDA receptor glycine site agonist | 0.091 0.021 CID_3015693 | CID_3015693 | |
| 0.035 | 0.022 | 0.035 | Adenosine uptake inhibitor | |||
| 0.053 | 0.041 | 0.053 | DNA helicase inhibitor | |||
| 0.042 | 0.031 | 0.044 | Carbonic anhydrase IV inhibitor | 0.044 0.029 CID_3015693 | CID_3015693 | |
| 0.087 | 0.077 | 0.087 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.088 | 0.08 | 0.088 | Phosphodiesterase 6D inhibitor | |||
| 0.063 | 0.055 | 0.063 | Potassium channel large-conductance Ca-activated activator | |||
| 0.071 | 0.064 | 0.071 | Antineoplastic antibiotic | 0.071 0.064 CID_3015693 | ||
| 0.091 | 0.085 | 0.091 | Beta glucuronidase inhibitor | |||
| 0.073 | 0.067 | 0.108 | Adrenaline agonist | 0.108 0.032 CID_3015693 | CID_3015693 | |
| 0.025 | 0.019 | 0.025 | Thyroid hormone agonist | 0.025 0.02 CID_3015693 | ||
| 0.016 | 0.01 | 0.016 | Antibiotic Tetracycline-like | |||
| 0.122 | 0.116 | 0.122 | Hexokinase inhibitor | |||
| 0.099 | 0.093 | 0.121 | M18 aspartyl aminopeptidase inhibitor | 0.121 0.07 CID_3015693 | CID_3015693 | |
| 0.041 | 0.038 | 0.071 | Glycine transporter 2 inhibitor | 0.071 0.02 CID_3015693 | CID_3015693 | |
| 0.114 | 0.112 | 0.114 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.094 | 0.092 | 0.115 | Topoisomerase II inhibitor | 0.115 0.071 CID_3015693 | CID_3015693 | |
| 0.056 | 0.054 | 0.056 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.086 | 0.085 | 0.086 | GABA C receptor agonist | 0.086 0.085 CID_3015693 | ||
| 0.176 | 0.175 | 0.176 | Transcription factor STAT inhibitor | |||
| 0.086 | 0.086 | 0.119 | Expectorant | 0.119 0.051 CID_3015693 | CID_3015693 | |
| 0.038 | 0.038 | 0.039 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.035 CID_3015693 | CID_3015693 | |
| 0.036 | 0.037 | 0.039 | Oxytocin agonist | 0.039 0.033 CID_3015693 | CID_3015693 | |
| 0.078 | 0.08 | 0.08 | Hematopoietic | 0.08 0.074 CID_3015693 | CID_3015693 | |
| 0.12 | 0.125 | 0.156 | GABA C receptor rho-2 antagonist | 0.156 0.066 CID_3015693 | CID_3015693 | |
| 0.121 | 0.132 | 0.127 | Melanin inhibitor | 0.127 0.121 CID_3015693 | CID_3015693 | |
| 0.034 | 0.045 | 0.058 | Phosphorylase inhibitor | 0.058 0.026 CID_3015693 | CID_3015693 | |
| 0.093 | 0.104 | 0.122 | CDK3/cyclin E inhibitor | 0.122 0.053 CID_3015693 | CID_3015693 | |
| 0.041 | 0.052 | 0.046 | Beta adrenoreceptor agonist | 0.046 0.028 CID_3015693 | CID_3015693 | |
| 0.071 | 0.083 | 0.087 | Myeloperoxidase inhibitor | 0.087 0.054 CID_3015693 | CID_3015693 | |
| 0.064 | 0.079 | 0.095 | Keratolytic | 0.095 0.034 CID_3015693 | CID_3015693 | |
| 0.029 | 0.047 | 0.041 | Dihydropteroate synthase inhibitor | 0.041 0.026 CID_3015693 | CID_3015693 | |
| 0.116 | 0.134 | 0.148 | Neuropeptide Y1 antagonist | 0.148 0.067 CID_3015693 | CID_3015693 | |
| 0.039 | 0.061 | 0.053 | Bombesin 2 receptor antagonist | 0.053 0.03 CID_3015693 | CID_3015693 | |
| 0.088 | 0.114 | 0.104 | Caspase 3 inhibitor | 0.104 0.086 CID_3015693 | CID_3015693 | |
| 0.11 | 0.138 | 0.153 | Growth hormone agonist | 0.153 0.085 CID_3015693 | CID_3015693 | |
| 0.052 | 0.08 | 0.063 | Heme oxygenase stimulant | 0.063 0.039 CID_3015693 | CID_3015693 | |
| 0.048 | 0.08 | 0.066 | Beta adrenoreceptor antagonist | 0.066 0.044 CID_3015693 | CID_3015693 | |
| 0.115 | 0.159 | 0.154 | Antipruritic | 0.154 0.09 CID_3015693 | CID_3015693 | |
| 0.146 | 0.191 | 0.278 | 5 Hydroxytryptamine release stimulant | 0.278 0.077 CID_3015693 | CID_3015693 | |
| 0.057 | 0.104 | 0.086 | Carbonic anhydrase VI inhibitor | 0.086 0.05 CID_3015693 | CID_3015693 | |
| 0.032 | 0.081 | 0.044 | Bombesin antagonist | 0.044 0.04 CID_3015693 | CID_3015693 | |
| 0.059 | 0.11 | 0.076 | Opioid antagonist | 0.076 0.075 CID_3015693 | CID_3015693 | |
| 0.037 | 0.092 | 0.062 | Sphingosine 1-phosphate receptor 3 antagonist | 0.062 0.035 CID_3015693 | CID_3015693 | |
| 0.037 | 0.1 | 0.064 | Carbonic anhydrase V inhibitor | 0.064 0.049 CID_3015693 | CID_3015693 | |
| 0.072 | 0.137 | 0.098 | GABA C receptor antagonist | 0.098 0.081 CID_3015693 | CID_3015693 | |
| 0.049 | 0.114 | 0.081 | Ornithine decarboxylase inhibitor | 0.081 0.066 CID_3015693 | CID_3015693 | |
| 0.079 | 0.148 | 0.104 | Factor V inhibitor | 0.104 0.06 CID_3015693 | CID_3015693 | |
| 0.067 | 0.137 | 0.091 | GABA C receptor rho-1 antagonist | 0.091 0.076 CID_3015693 | CID_3015693 | |
| 0.063 | 0.196 | 0.106 | Glutamate (mGluR7) agonist | 0.106 0.048 CID_3015693 | CID_3015693 | |
| 0.063 | 0.239 | 0.111 | Histone deacetylase SIRT1 inhibitor | 0.111 0.102 CID_3015693 | CID_3015693 | |
| 0.037 | 0.239 | 0.089 | Bronchodilator | 0.089 0.076 CID_3015693 | CID_3015693 | |
| 0.014 | 0.339 | 0.063 | DNA gyrase inhibitor | 0.063 0.044 CID_3015693 | CID_3015693 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |